Trial Profile
Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines: A Phase I Trial to Assess Safety and Immune Response.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Tyrosinase DNA vaccine (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Pharmacodynamics
- 15 Sep 2011 Actual end date (September 2011) added as reported by ClinicalTrials.gov.
- 15 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jul 2008 New trial record.